NM_001370259.2(MEN1):c.208G>A (p.Asp70Asn) AND Multiple endocrine neoplasia, type 1

Germline classification:: Uncertain significance (2 submissions)
Last evaluated:: Oct 26, 2023
Review status:: 2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001305245.8

Allele description [Variation Report for NM_001370259.2(MEN1):c.208G>A (p.Asp70Asn)]

NM_001370259.2(MEN1):c.208G>A (p.Asp70Asn)

Gene:

MEN1:menin 1 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

11q13.1

Genomic location:

Preferred name:

NM_001370259.2(MEN1):c.208G>A (p.Asp70Asn)

HGVS:

NC_000011.10:g.64809902C>T
NG_008929.1:g.6393G>A
NM_000244.4:c.208G>A
NM_001370251.2:c.208G>A
NM_001370259.2:c.208G>AMANE SELECT
NM_001370260.2:c.208G>A
NM_001370261.2:c.208G>A
NM_001370262.2:c.208G>A
NM_001370263.2:c.208G>A
NM_130799.3:c.208G>A
NM_130800.3:c.208G>A
NM_130801.3:c.208G>A
NM_130802.3:c.208G>A
NM_130803.3:c.208G>A
NM_130804.3:c.208G>A
NP_000235.3:p.Asp70Asn
NP_001357180.2:p.Asp70Asn
NP_001357188.2:p.Asp70Asn
NP_001357189.2:p.Asp70Asn
NP_001357190.2:p.Asp70Asn
NP_001357191.2:p.Asp70Asn
NP_001357192.2:p.Asp70Asn
NP_570711.2:p.Asp70Asn
NP_570712.2:p.Asp70Asn
NP_570713.2:p.Asp70Asn
NP_570714.2:p.Asp70Asn
NP_570715.2:p.Asp70Asn
NP_570716.2:p.Asp70Asn
LRG_509t2:c.208G>A
LRG_509:g.6393G>A
NC_000011.9:g.64577374C>T
NM_130799.2:c.208G>A

Protein change:

D70N

Links:

dbSNP: rs1283021293

NCBI 1000 Genomes Browser:

rs1283021293

Molecular consequence:

NM_000244.4:c.208G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001370251.2:c.208G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001370259.2:c.208G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001370260.2:c.208G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001370261.2:c.208G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001370262.2:c.208G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001370263.2:c.208G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_130799.3:c.208G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_130800.3:c.208G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_130801.3:c.208G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_130802.3:c.208G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_130803.3:c.208G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_130804.3:c.208G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Multiple endocrine neoplasia, type 1 (MEN1)
Synonyms:: MEA I; MEN I; Endocrine adenomatosis multiple; See all synonyms [MedGen]
Identifiers:: MONDO: MONDO:0007540; MeSH: D018761; MedGen: C0025267; Orphanet: 652; OMIM: 131100

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001494574	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Mar 7, 2022)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]
SCV004194425	Baylor Genetics	criteria provided, single submitter (ACMG Guidelines, 2015)	Uncertain significance (Oct 26, 2023)	unknown	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001494574

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Mar 7, 2022)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

SCV004194425

Baylor Genetics

criteria provided, single submitter

(ACMG Guidelines, 2015)

Uncertain significance
(Oct 26, 2023)

unknown

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing
not provided	unknown	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001494574.4

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 1007982). This variant has not been reported in the literature in individuals affected with MEN1-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 70 of the MEN1 protein (p.Asp70Asn).

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

From Baylor Genetics, SCV004194425.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	unknown	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine